FP
KLDO

Flagship Pioneering’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Flagship Pioneering’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,575,710
Closed -$32.3M – 13
2022
Q1 		$32.3M Hold
19,575,710
– – 0.76% 10
2021
Q4 		$46.8M Hold
19,575,710
– – 0.72% 9
2021
Q3 		$107M Hold
19,575,710
– – 1.12% 8
2021
Q2 		$146M Hold
19,575,710
– – 1.86% 7
2021
Q1 		$159M Buy
19,575,710
+215,000
+1% +$2.34M 2.54% 8
2020
Q4 		$176M Hold
19,360,710
– – 3.21% 8
2020
Q3 		$214M Hold
19,360,710
– – 5.92% 3
2020
Q2 		$144M Buy
19,360,710
+2,000,000
+12% +$13.4M 4.18% 4
2020
Q1 		$107M Hold
17,360,710
– – 5% 4
2019
Q4 		$87.2M Hold
17,360,710
– – 4.87% 4
2019
Q3 		$131M Hold
17,360,710
– – 7.15% 3
2019
Q2 		$201M Hold
17,360,710
– – 8.72% 3
2019
Q1 		$252M Buy
+17,360,710
New +$239M 9.53% 3

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Flagship Pioneering's KLDO Position: Q2 2022 in Review

Flagship Pioneering sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 19,575,710 shares — an estimated $32.3M sold.

Flagship Pioneering first reported a position in KLDO in Q1 2019 and held it in 13 quarters. The position peaked at $252M in Q1 2019. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Flagship Pioneering reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Flagship Pioneering sold 19,575,710 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $32.3M.
  • Flagship Pioneering first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Flagship Pioneering's Kaleido Biosciences, Inc. Common Stock position peaked at $252M in Q1 2019.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Flagship Pioneering's 13F filing for Q2 2022, filed 15 Aug 2022.